Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × ACTH Syndrome, Ectopic × Osilodrostat × Clear all

Phase

Phase 4 2 Phase 2 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Cushing Syndrome 1 Adrenal Cortex Neoplasms 1 Acth-Independent Macronodular Adrenal Hyperplasia 1 ACTH Syndrome, Ectopic 1

Interventions

relacorilant 2 Metyrapone 2 pasireotide 1 Osilodrostat 1 ASP3662 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02468193 2020-05-06

Study of Efficacy and Safety of Osilodrostat in Cushing's Syndrome

Novartis

Phase 2 Completed

9 enrolled 22 charts

Acth-Independent Macronodular Adrenal Hyperplasia, ACTH Syndrome, Ectopic, Adrenal Cortex Neoplasms, Cushing Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon ⚡